Table 1.
Site | No of nets (no tested in bio-assay) | Deltamethrin concentration (mg/m 2 ) (by XRF) Mean (SD) | No (%) of nets with <10 mg/m 2 deltamethrin | Manufacturer’s reported batch mean deltamethrin concentration (MRBMC) (mg/m 2 ) | Difference between field XRF and MRBMC (%) | |
---|---|---|---|---|---|---|
A |
|
25 (4) |
64.7 (13.3) |
0 |
59.9 |
8.0 |
B |
|
25 (4) |
67.6 (10.8) |
0 |
59.9 |
12.9 |
C |
|
25 (4) |
69.7 (14.3) |
0 |
59.7 |
16.8 |
D |
|
25 (4) |
74.8 (12.5) |
0 |
59.7 |
25.3 |
E |
|
25 (4) |
58.0 (14.3) |
0 |
60.0 |
-3.3 |
F |
|
25 (4) |
58.1 (20.0) |
1 (4) |
60.0 |
-3.2 |
G |
|
5 (0) |
76.9 (5.6) |
0 |
58.9 |
30.6 |
H |
|
14 (0) |
72.9 (9.5) |
0 |
58.9 |
23.8 |
J |
|
20 (4) |
63.8 (8.6) |
0 |
60.9 |
4.8 |
|
3–6 months
|
189 (28)
|
66.2 (14.6)
|
1 (0.5)
|
59.8*
|
10.8
|
K |
|
20 (4) |
53.2 (15.9) |
0 |
59.9 |
-11.2 |
L |
|
20 (4) |
38.1 (19.9) |
1 (5) |
59.1 |
-35.5 |
M |
|
20 (4) |
58.5 (14.7) |
0 |
59.1 |
-1.0 |
N |
|
20 (4) |
41.6 (19.3) |
1 (5) |
59.7 |
-30.3 |
P |
|
20 (4) |
46.9 (19.9) |
0 |
57.7 |
-18.7 |
Q |
|
20 (4) |
48.1 (19.0) |
0 |
59.1 |
-18.6 |
R |
|
20 (4) |
30.7 (26.8) |
6 (30) |
60.0 |
-48.8 |
S |
|
20 (4) |
50.4 (26.0) |
1 (5) |
61.0 |
-17.4 |
T |
|
20 (4) |
47.1 (18.0) |
0 |
58.9 |
-20.0 |
U |
|
20 (4) |
41.6 (19.3) |
1 (5) |
59.1 |
-29.6 |
J |
|
20 (4) |
28.7 (14.5) |
2 (10) |
60.9 |
-52.9 |
|
14-20 months
|
220 (44)
|
44.1 (21.2)
|
12 (5.5)
|
59.5*
|
-25.9
|
K |
|
20 (4) |
40.0 (19.3) |
2 (10) |
59.9 |
-33.2 |
L |
|
20 (4) |
46.6 (13.9) |
0 |
59.1 |
-21.2 |
M |
|
20 (4) |
54.3 (21.1) |
0 |
59.1 |
-8.1 |
N |
|
20 (4) |
34.1 (14.7) |
0 |
59.7 |
-42.9 |
P |
|
20 (4) |
35.5 (16.6) |
1 (5) |
57.7 |
-38.5 |
Q |
|
20 (4) |
42.0 (18.7) |
0 |
59.1 |
-28.9 |
R |
|
20 (4) |
32.5 (18.0) |
4 (20) |
60.0 |
-45.8 |
S |
|
20 (4) |
45.3 (20.7) |
0 |
61.0 |
-25.7 |
T |
|
20 (4) |
38.0 (14.0) |
0 |
58.9 |
-35.5 |
U |
|
20 (4) |
42.4 (23.2) |
1 (5) |
59.1 |
-28.3 |
26-32 months | 200 (40) | 41.1 (18.9) | 8 (4.0) | 59.4* | -30.8 |
*Average of the sites in the time group of collection.